Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy

被引:0
作者
Yu-Te Huang
Peng-Tai Tien
Po-Yu Chen
Chi-Lan Yang
San-Ni Chen
机构
[1] China Medical University Hospital,Department of Ophthalmology, Eye Center
[2] China Medical University,School of Medicine, College of Medicine
来源
Graefe's Archive for Clinical and Experimental Ophthalmology | 2024年 / 262卷
关键词
Brolucizumab; Half-dose PDT; Aflibercept; Chronic central serous chorioretinopathy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1755 / 1763
页数:8
相关论文
共 147 条
[1]  
van Rijssen TJ(2019)Central serous chorioretinopathy: towards an evidence-based treatment guideline Prog Retin Eye Res 73 100770-139
[2]  
van Dijk EHC(1967)Pathogenesis of disciform detachment of the neuroepithelium Am J Ophthalmol 63 1-552
[3]  
Yzer S(1988)New hypotheses on the pathogenesis and treatment of serous retinal detachment Graefes Arch Clin Exp Ophthalmol 1226 548-33
[4]  
Gass JD(2019)Pachychoroid disease Eye (Lond) 33 14-1915
[5]  
Marmor MF(2017)Acute central serous chorioretinopathy: factors influencing episode duration Retina 37 1905-2234
[6]  
Cheung CMG(2008)Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage Ophthalmology 115 2229-614
[7]  
Lee WK(2023)Comparing interventions for chronic central serous chorioretinopathy: a network meta-analysis Surv Ophthalmol 68 601-159
[8]  
Koizumi H(2023)Comparative efficacy of treatments for chronic central serous chorioretinopathy: a systematic review with network meta-analyses Acta Ophthalmol 101 140-1077
[9]  
Dansingani K(2015)Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy Br J Ophthalmol 99 1070-99
[10]  
Lai TYY(2016)A multicenter study on the long-term outcomes of half-dose photodynamic therapy in chronic central serous chorioretinopathy Am J Ophthalmol 170 91-98